Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study
Abstract Background In the UK, hepatitis B virus (HBV) incidence is associated with migrants from particular high-burden countries and population groups deemed ‘hard-to-reach’ by standard healthcare services: the homeless, people who inject drugs and ex-prisoners. Currently, there is a national targ...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-019-3926-2 |
id |
doaj-d6f31fe8190a4fb6b9fee1f87beb0503 |
---|---|
record_format |
Article |
spelling |
doaj-d6f31fe8190a4fb6b9fee1f87beb05032020-11-25T03:16:20ZengBMCBMC Infectious Diseases1471-23342019-05-011911910.1186/s12879-019-3926-2Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional studyJosephine E. B. Taylor0Julian Surey1Jennifer MacLellan2Marie Francis3Ibrahim Abubakar4Helen R. Stagg5Institute for Global Health, University College London, 4th floor, Mortimer Market CentreInstitute for Global Health, University College London, 4th floor, Mortimer Market CentreInstitute for Global Health, University College London, 4th floor, Mortimer Market CentreInstitute for Global Health, University College London, 4th floor, Mortimer Market CentreInstitute for Global Health, University College London, 4th floor, Mortimer Market CentreInstitute for Global Health, University College London, 4th floor, Mortimer Market CentreAbstract Background In the UK, hepatitis B virus (HBV) incidence is associated with migrants from particular high-burden countries and population groups deemed ‘hard-to-reach’ by standard healthcare services: the homeless, people who inject drugs and ex-prisoners. Currently, there is a national targeted HBV vaccine policy for such at-risk groups, but there is limited recent evidence about 1) the levels of vaccine uptake, 2) the factors associated with incomplete vaccination, and 3) reasons for incomplete vaccination. Methods A questionnaire capturing social and medical history, demographic factors and information about HBV vaccination status was completed by individuals deemed hard-to-reach due to socio-structural factors that criminalise, isolate and stigmatise who consented to participate in a randomised controlled trial of a peer intervention to promote engagement with hepatitis C services. The questionnaire also captured the reasons for incomplete vaccination. Descriptive, univariable and multivariable regression analyses were undertaken. Results Three hundred fourty six participants completed the questionnaire. 1) 52.3% (n = 181) reported full HBV vaccination. 2) Within a multivariable model adjusting for sociodemographic variables, the presence of one or two or more socio-structural factors that are included in the national targeted vaccination policy was associated with protection against incomplete HBV vaccination (51.7% vaccine coverage in those with one factor, odds ratio 0.43 [95% confidence interval 0.20–0.92]); 70.1% coverage with two or more factors, 0.19 [0.09–0.39]; overall p-value < 0.001). Being female was also associated with lower vaccine uptake (2.37 [1.24–4.57], 0.01). Examining the socio-structural factors individually, intravenous drug use was associated with protection against incomplete HBV vaccination. 3) The most common reasons declared for incomplete vaccination were never being offered the vaccine or not returning for further doses. Conclusion Within this study of HBV vaccination uptake among hard-to-reach population groups in London, UK, we document 52.3% coverage of the full vaccine course. Critically, although participants recommended for immunisation within national guidelines had an increased likelihood of receiving a complete vaccine course, we note surprisingly low coverage in the presence of the risk factors that are national indicators for vaccination. Public health bodies should make additional efforts to improve coverage in the hard-to-reach through improved vaccine delivery systems. Trial registration ISRCTN24707359, Registered 19th October 2012.http://link.springer.com/article/10.1186/s12879-019-3926-2Hepatitis B virusVaccinationHard-to-reachPrisonersHomelessInjecting drug users |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Josephine E. B. Taylor Julian Surey Jennifer MacLellan Marie Francis Ibrahim Abubakar Helen R. Stagg |
spellingShingle |
Josephine E. B. Taylor Julian Surey Jennifer MacLellan Marie Francis Ibrahim Abubakar Helen R. Stagg Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study BMC Infectious Diseases Hepatitis B virus Vaccination Hard-to-reach Prisoners Homeless Injecting drug users |
author_facet |
Josephine E. B. Taylor Julian Surey Jennifer MacLellan Marie Francis Ibrahim Abubakar Helen R. Stagg |
author_sort |
Josephine E. B. Taylor |
title |
Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study |
title_short |
Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study |
title_full |
Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study |
title_fullStr |
Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study |
title_full_unstemmed |
Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study |
title_sort |
hepatitis b vaccination uptake in hard-to-reach populations in london: a cross-sectional study |
publisher |
BMC |
series |
BMC Infectious Diseases |
issn |
1471-2334 |
publishDate |
2019-05-01 |
description |
Abstract Background In the UK, hepatitis B virus (HBV) incidence is associated with migrants from particular high-burden countries and population groups deemed ‘hard-to-reach’ by standard healthcare services: the homeless, people who inject drugs and ex-prisoners. Currently, there is a national targeted HBV vaccine policy for such at-risk groups, but there is limited recent evidence about 1) the levels of vaccine uptake, 2) the factors associated with incomplete vaccination, and 3) reasons for incomplete vaccination. Methods A questionnaire capturing social and medical history, demographic factors and information about HBV vaccination status was completed by individuals deemed hard-to-reach due to socio-structural factors that criminalise, isolate and stigmatise who consented to participate in a randomised controlled trial of a peer intervention to promote engagement with hepatitis C services. The questionnaire also captured the reasons for incomplete vaccination. Descriptive, univariable and multivariable regression analyses were undertaken. Results Three hundred fourty six participants completed the questionnaire. 1) 52.3% (n = 181) reported full HBV vaccination. 2) Within a multivariable model adjusting for sociodemographic variables, the presence of one or two or more socio-structural factors that are included in the national targeted vaccination policy was associated with protection against incomplete HBV vaccination (51.7% vaccine coverage in those with one factor, odds ratio 0.43 [95% confidence interval 0.20–0.92]); 70.1% coverage with two or more factors, 0.19 [0.09–0.39]; overall p-value < 0.001). Being female was also associated with lower vaccine uptake (2.37 [1.24–4.57], 0.01). Examining the socio-structural factors individually, intravenous drug use was associated with protection against incomplete HBV vaccination. 3) The most common reasons declared for incomplete vaccination were never being offered the vaccine or not returning for further doses. Conclusion Within this study of HBV vaccination uptake among hard-to-reach population groups in London, UK, we document 52.3% coverage of the full vaccine course. Critically, although participants recommended for immunisation within national guidelines had an increased likelihood of receiving a complete vaccine course, we note surprisingly low coverage in the presence of the risk factors that are national indicators for vaccination. Public health bodies should make additional efforts to improve coverage in the hard-to-reach through improved vaccine delivery systems. Trial registration ISRCTN24707359, Registered 19th October 2012. |
topic |
Hepatitis B virus Vaccination Hard-to-reach Prisoners Homeless Injecting drug users |
url |
http://link.springer.com/article/10.1186/s12879-019-3926-2 |
work_keys_str_mv |
AT josephineebtaylor hepatitisbvaccinationuptakeinhardtoreachpopulationsinlondonacrosssectionalstudy AT juliansurey hepatitisbvaccinationuptakeinhardtoreachpopulationsinlondonacrosssectionalstudy AT jennifermaclellan hepatitisbvaccinationuptakeinhardtoreachpopulationsinlondonacrosssectionalstudy AT mariefrancis hepatitisbvaccinationuptakeinhardtoreachpopulationsinlondonacrosssectionalstudy AT ibrahimabubakar hepatitisbvaccinationuptakeinhardtoreachpopulationsinlondonacrosssectionalstudy AT helenrstagg hepatitisbvaccinationuptakeinhardtoreachpopulationsinlondonacrosssectionalstudy |
_version_ |
1724636767409143808 |